APOE and Alzheimer disease: Meanwhile, given that such effects are only observed in female APOE-ε4 carriers, they are likely masked in recent genetic studies of AD, in both the overall population (P = 0.881)87 and APOE-ε4 carriers (P = 0.798)88.